Story perspectives
Morning Rounds Returns: Mental Health, GLP-1 Breakthroughs Ahead
7/15/2025
32 3
1 of 1
Story summary
- Theresa Gaffney heads Morning Rounds, emphasizing health care, research, and public policy, particularly in mental health and LGBTQ+ matters.
- The newsletter resumes, offering daily health updates.
- GLP-1 medications may help with cravings and addiction, though limited clinical trials are underway.
- Publication of trial results could take up to two years.
